Physician profile
David Mark Perim
NPI 1689666190
$15,748.75
in general payments reported to CMS, 2019-2025
42 companies · $3,448 in 2025
The $3,448 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,713 · 2020: $950 · 2021: $2,405 · 2022: $2,198 · 2023: $1,868 · 2024: $1,168 · 2025: $3,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,980 · Travel and Lodging: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,980.30 |
| Travel and Lodging | $1,503.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,464.95 | 2019-2023 | Other - Miscellaneous |
| Providence Medical Technology, INC. | $2,378.82 | 2019-2025 | |
| Medtronic USA, INC. | $1,926.83 | 2019-2020 | |
| Stryker Corporation | $1,832.06 | 2019-2025 | Hoffmann, Gamma, Pangea |
| Medtronic, INC. | $1,776.14 | 2021-2025 | Osteocool Rf Ablation System, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $466.49 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $450.83 | 2019-2024 | Euflexxa |
| Supreme Orthopedic Systems, LLC | $425.49 | 2022-2025 | |
| Spinal Elements, INC. | $397.57 | 2023 | |
| Biocomposites INC | $358.19 | 2023-2025 | Stimulan |
| Surgalign Spine Technologies, INC. | $257.55 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $239.11 | 2023-2025 | Zilretta, Iovera, Exparel |
| Pacira Therapeutics, INC. | $235.38 | 2019-2021 | |
| Innovation Technologies INC | $226.14 | 2023 | Irrisept |
| Depuy Synthes Sales INC. | $193.69 | 2019-2024 | Trumatch |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $189.65 | 2022 | |
| Globus Medical, INC. | $178.15 | 2021-2025 | Vyrsa V1 |
| Spinal Simplicity, LLC | $171.49 | 2025 | Ha Minuteman G3-R |
| Smith+Nephew, INC. | $153.26 | 2019-2025 | Pico 7 |
| Axogen | $136.80 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Sanara Medtech INC. | $120.81 | 2024 | Celleraterx |
| Captiva Spine INC | $113.32 | 2025 | Caplox II |
| Arthrex, INC. | $110.90 | 2021 | |
| Ossio INC | $100.20 | 2023 | |
| Abbott Laboratories | $97.06 | 2024 | Proclaim |
| Avanos Medical | $79.83 | 2025 | Standard Rf Disposables |
| Horizon Therapeutics Plc | $75.67 | 2019-2022 | |
| Amgen INC. | $72.76 | 2019-2025 | Krystexxa, Prolia, Evenity |
| Arteriocyte Medical Systems, INC. | $67.91 | 2019 | |
| Xtant Medical INC | $66.83 | 2023 | |
| Nevro Corp. | $64.50 | 2024 | Senza |
| Skeletal Dynamics INC | $60.31 | 2024 | Implate, Align, Geminus |
| Painteq LLC | $46.80 | 2024 | Painteq |
| Ethicon US, LLC | $41.61 | 2025 | Surgicel Nu-Knit, Stratafix, Vistaseal |
| 4web, INC. | $29.18 | 2021 | |
| Misonix INC | $25.41 | 2021 | |
| Centinel Spine, LLC | $24.73 | 2024 | Prodisc C Vivo |
| Relievant Medsystems, INC. | $22.24 | 2022 | |
| Fidia Pharma USA INC. | $22.05 | 2025 | Hymovis, Triluron |
| Vertos Medical, INC. | $17.88 | 2022 | |
| Spine Wave, INC. | $16.52 | 2022 | |
| Clarus Therapeutics INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Perim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.